SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Pervasis Therapeutics Receives Orphan Drug Designation in Europe for Vascugel(R) to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis